HKD 62.75
(-1.34%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -1.05 Billion CNY | -392.82% |
2022 | -213.27 Million CNY | 88.03% |
2021 | -1.78 Billion CNY | 28.3% |
2020 | -2.48 Billion CNY | -140.38% |
2019 | -1.03 Billion CNY | -315.81% |
2018 | -248.66 Million CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | 814.94 Million CNY | 0.0% |
2023 FY | -1.05 Billion CNY | -392.82% |
2023 Q2 | -1.87 Billion CNY | 0.0% |
2023 Q4 | -1.05 Billion CNY | 0.0% |
2022 FY | -213.27 Million CNY | 88.03% |
2022 Q2 | -1.05 Billion CNY | 0.0% |
2022 Q4 | -239.45 Million CNY | 0.0% |
2021 FY | -1.78 Billion CNY | 28.3% |
2021 Q2 | -3.25 Billion CNY | 0.0% |
2021 Q4 | -2.18 Billion CNY | 0.0% |
2020 Q4 | -2.94 Billion CNY | 0.0% |
2020 FY | -2.48 Billion CNY | -140.38% |
2020 Q2 | -3.5 Billion CNY | 0.0% |
2019 Q4 | 147.91 Million CNY | 0.0% |
2019 FY | -1.03 Billion CNY | -315.81% |
2019 Q2 | -141.4 Million HKD | 0.0% |
2018 FY | -248.66 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | -76.36 Million HKD | -1276.323% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 119.957% |